Takeda Pharmaceutical (TAK) Consolidated Net Income (2017 - 2026)
Takeda Pharmaceutical (TAK) recorded Consolidated Net Income of $710.56 million in the quarter ended Jun 30, 2026, down 17.3% from $858.91 million a year earlier and down 10.4% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Consolidated Net Income (2017 - 2026) Analysis & Trends
On a TTM basis, Takeda Pharmaceutical's Consolidated Net Income came in at $577.31 million as of Jun 30, 2026, down 76.1% year-over-year; for the year ended Mar 31, 2026, it was -$1.01 billion.
- Across earlier years, Consolidated Net Income came in at $709.94 million in the year ended Mar 31, 2025 (-29.0%), $999.88 million in the year ended Mar 31, 2024 (-57.4%), $2.35 billion in the year ended Mar 31, 2023 (+14.5%) and $2.05 billion in the year ended Mar 31, 2022 (-42.2%).
- Quarterly Consolidated Net Income has ranged from -$2.39 billion in the quarter ended Dec 31, 2025 to $1.98 billion in the quarter ended Sep 30, 2023 over the past five years.
- On a year-over-year basis, Consolidated Net Income rose in three of the last six quarters, with growth averaging 3.7%.
- Peak year-over-year performance for Consolidated Net Income in the last five years was growth of 342.9% in the quarter ended Sep 30, 2023, against a decline of 75.1% in the quarter ended Dec 31, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $792.61 million (quarter ended Mar 31, 2026), -$2.39 billion (quarter ended Dec 31, 2025) and $1.47 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Takeda Pharmaceutical | 2.58 Bn | -23.92 Bn | 5.10 Bn | 710.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 710.56 Mn |
| Mar 31, 2026 | 792.61 Mn |
| Dec 31, 2025 | -2.39 Bn |
| Sep 30, 2025 | 1.47 Bn |
| Jun 30, 2025 | 858.91 Mn |
| Mar 31, 2025 | 814.74 Mn |
| Dec 31, 2024 | -678.17 Mn |
| Sep 30, 2024 | 1.42 Bn |
| Jun 30, 2024 | 612.19 Mn |
| Mar 31, 2024 | 643.07 Mn |
| Dec 31, 2023 | 210.40 Mn |
| Sep 30, 2023 | 1.98 Bn |
| Jun 30, 2023 | 652.39 Mn |
| Mar 31, 2023 | 793.80 Mn |
| Dec 31, 2022 | 843.37 Mn |
| Sep 30, 2022 | 446.97 Mn |
| Jun 30, 2022 | 812.06 Mn |
| Mar 31, 2022 | 1.18 Bn |
| Jun 30, 2021 | 1.26 Bn |
| Mar 31, 2021 | 1.89 Bn |
API Access
Takeda Pharmaceutical Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();